Real-world experience of adjunct weekly semaglutide in Type 1 diabetes. Is it worth it?

被引：0
|
作者：
Cohen, Neale [1 ]
Yeung, Asher [1 ,2 ]
Jenkins, Alicia [1 ,2 ]
机构：
[1] Baker Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia
[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2025年 / 219卷
关键词：
METABOLIC SYNDROME;
D O I：
10.1016/j.diabres.2024.111979
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Reality of Real-World Experience with Oral Semaglutide in Type 2 Diabetes
    Singh, Awadhesh Kumar
    Singh, Akriti
    Singh, Ritu
    Swain, Jayshree
    CLINICAL DIABETOLOGY, 2024, 13 (06): : 319 - 322
  • [2] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
    Menzen, Markus
    Berentzen, Tina Landsvig
    Catarig, Andrei-Mircea
    Pieperhoff, Sebastian
    Simon, Joerg
    Jacob, Stephan
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2023, 131 (04) : 205 - 215
  • [3] Efficacy and Safety of Once-Weekly Semaglutide in People with Type 1 Diabetes in Real-World Practice
    Bellido, Virginia
    Herguido, Noelia Gros
    Amuedo, Sandra
    Ariza, Luis Baena
    Alfonso, Soto M.
    DIABETES, 2023, 72
  • [4] Semaglutide Once Weekly In Persons with Type 2 Diabetes: Real-World Analysis of the Colombian Diabetes Registry (COL-REAL 1 Study)
    Mario Balcazar, Carlos
    Zambrano, Jose
    Felipe Garcia, Andres
    Eugenia Casanova, Maria
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 69 - 70
  • [5] Real-world Evidence on Oral Semaglutide for the Management of Type 2 Diabetes. A Narrative Review for Clinical Practice
    Marassi, M.
    Fadini, G. P.
    CLINICAL THERAPEUTICS, 2025, 47 (01) : 102 - 110
  • [6] Semaglutide once weekly in people with type 2 diabetes: Real-world analysis of the CanadianLMCdiabetes registry (SPAREstudy)
    Brown, Ruth E.
    Bech, Peter G.
    Aronson, Ronnie
    DIABETES OBESITY & METABOLISM, 2020, 22 (11): : 2013 - 2020
  • [7] Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme
    Yale, Jean-Francois
    Major-Pedersen, Atheline
    Catarig, Andrei-Mircea
    Jain, Rashmi
    Menzen, Markus
    Holmes, Patrick
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4429 - 4440
  • [8] A district general hospital real-world experience of the use of semaglutide in patients with type 2 diabetes
    Liarakos, A. L.
    Smith, L.
    Patel, K.
    Mani, H.
    Pierides, M.
    DIABETIC MEDICINE, 2020, 37 : 131 - 131
  • [9] Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain
    Garcia de Lucas, Maria Dolores
    Pablo Miramontes-Gonzalez, Jose
    Aviles-Bueno, Beatriz
    Isabel Jimenez-Millan, Ana
    Rivas-Ruiz, Francisco
    Perez-Belmonte, Luis M.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Safety profile of once-weekly subcutaneous semaglutide in a real-world adult population with type 2 diabetes
    Yale, J. -F.
    Major-Pedersen, A.
    Catarig, A. -M.
    Jain, R. G.
    Menzen, M.
    Holmes, P.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S339 - S340
12345